Milestone Scientific Inc Dossier
Qualitative Analysis
Business overview
Milestone Scientific Inc. (NYSE American: MLSS) is a biomedical technology company that patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies and devices for medical and dental use. The company's core technology platform is its proprietary Dynamic Pressure Sensing (DPS) Technology, which controls flow rate and measures pressure at the needle tip in real time. Milestone operates through two primary segments: Dental, which markets computerized local anesthesia delivery systems such as the STA Single Tooth Anesthesia System and The Wand; and Medical, which focuses on computerized drug delivery instruments, notably the CompuFlo Epidural System used for identifying the epidural space in regional anesthesia procedures.
Research as of 20 Jun 2026
Strategic Initiatives
Growth programs, investments, and their expected impact
A strategic initiative launched on February 1, 2026, targeting high-volume interventional pain and anesthesia practices within key Medicare Administrative Contractor (MAC) jurisdictions (Novitas, First Coast, Noridian, and Palmetto).
Expected impact: Designed to drive mainstream commercial adoption, increase recurring disposable revenue, and generate clinical data necessary to optimize long-term Medicare reimbursement rates.
Following a pilot launch in December 2025, the program was taken national in January 2026 to spark renewed engagement and drive domestic sales of the Single Tooth Anesthesia (STA) system.
Expected impact: Anticipated to contribute a few hundred thousand dollars in new sales and increase domestic market penetration from its current level of under 2%.
Mergers, Acquisitions & Partnerships
Recent deals and strategic collaborations
Strategic Partnerships
Grants Axial Biologics the right to distribute the CompuFlo® Epidural System in New Jersey, Texas, and Florida, leveraging their established clinician relationships in the pain management sector.
Terms: Not disclosed
Secures a 12-month lock-up on shares held via BP4 S.r.l. (which owns 11.31% of Milestone's common stock) to facilitate capital-raising efforts and maintain orderly trading.
Terms: Amended definitions of 'Qualified Offering' and 'Other Locked-Up Parties' to support a planned securities offering.